2023-03-09
Recently, the People's Government of Zhaoqing City, Guangdong Province, released a commendation for the top 50 technologically innovative enterprises of 2022, and our company was honored with the title of "One of the Top 50 Technologically Innovative Enterprises in Zhaoqing City for the Year 2022."
In 2022, Dahuanong overcame the continuous impact of the COVID-19 pandemic and extreme competition in the industry. By leveraging the driving force of technological innovation and the concerted efforts of the team, the company achieved a "double harvest" in both technological innovation and business performance. It won the first prize of the Guangdong Province Science and Technology Progress Award, 5 new veterinary drugs (including one Category I new veterinary drug), and 26 authorized invention patents. It was selected as a part of the Guangdong Modern Agriculture Microbial Specialty Industrial Park and recognized as a Guangdong Specialized, Fined, Peculiar and Innovative (SFPI) small and medium-sized enterprise. The innovative achievements have contributed to the high-quality development of the business and made a positive contribution to the local economic development.
In the future, Dahuanong will continue to take on the mission of "being an expert in animal health care and serving human health." It will focus on the "345" project to create a technological driving force and achieve leading innovative goals. It will transform the three core technologies of "subunits, new adjuvants, and bio-fermentation" into advantages of large-scale application and promote the extension of the industrial chain. The company will continue to promote high-quality development, forge ahead bravely, and continue to strengthen technological innovation and cooperation, constantly promoting the advancement of corporate technology, fulfilling its social and economic responsibilities, and making greater contributions to accelerating local construction.